It seems, as per MENSCRIPT the online health clinic that is specialized in providing online treatments for hair loss within the United Kingdom and the Netherlands the answer is no.
The health clinic online conducted an inquiry into the scientific basis of saw palmetto as well as hair loss and found that the majority studies cited by the manufacturer to provide “proof” for their efficacy is believed to have been financial supported by the business.
They found that despite saw palmetto being touted on the internet to be an effective remedy against hair loss it does not significantly reduce the amount of DHT (dihydrotestosterone). A hormone that is believed to be the reason behind male hair loss.
They also found for example that DHT inhibition that is commonly mentioned is very weak and has no clinical significance at all for stopping the loss of hair. Finasteride, for instance, is 18.000 times more powerful when it comes to blocking enzyme type II when compared with Saw Palmetto.
The reason that Saw Palmetto is still regarded as a potent DHT blocker in the present day appears to be result of the marketing team that runs this Permixon brand. The brand is controlled by Pierre Fabre Laboratories; a pharmaceutical company which published two studies in 1984 and in 1996 that were both carried out by their own research team as well as the research facilities they own that is, the Centre de Recherches Pierre Fabre
A study conducted in a laboratory where cells were exposed to very high doses of saw palmetto which could have ruined the cellular function. According to MENSCRIPT, the study is clear that the claims about hair loss are not true and are mostly an attempt to boost sales for the company that is behind it.
For the full analysis visit their website: Saw palmetto for hair loss: popular but ineffective